Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A Publications section was added to the study record, listing a Nat Commun article about the related pembrolizumab/DPX-Survivac/cyclophosphamide trial and noting that publications are automatically filled from PubMed (Revision: v3.5.4).
    Difference
    0.3%
    Check dated 2026-05-18T03:28:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    There are no textual changes listed for this page in the provided data.
    Difference
    0.1%
    Check dated 2026-05-10T21:53:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page footer was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” reflecting a new ClinicalTrials.gov site/record display revision without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-26T08:24:06.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T08:56:25.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added revision note for v3.4.3 and removed the previous v3.4.2 revision.
    Difference
    0.1%
    Check dated 2026-03-06T19:04:29.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the Conditions section. A new page revision tag shows Revision: v3.4.2 (replacing v3.4.1).
    Difference
    0.1%
    Check dated 2026-02-13T07:44:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.